1. Respiratory Inflammation and Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden
2. Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, and
3. Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
4. Cenix Bioscience GmbH, Dresden, Germany
5. AstraZeneca Research and Development, Charnwood, Loughborough, United Kingdom
6. Cenix Bioscience, Minneapolis, Minnesota; and
7. Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, United Kingdom